Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Roth David Create: Alert

All | News | Filings
Date FiledTypeDescription
08/02/2023 4 Roth David (Chief Medical Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Sold 7,348 shares @ $3.95, valued at $29k
07/31/2023 144 Form 144 - Report of proposed sale of securities:
04/04/2023 4 Roth David (Chief Medical Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 623 shares @ $2.58, valued at $1.6k
Exercised 2,000 restricted stock units @ $0
10/11/2022 4 Roth David (Chief Medical Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 49,750 options to buy @ $6.73, valued at $334.8k
Granted 37,750 restricted stock units @ $0
07/11/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
04/04/2022 4 Roth David (Chief Medical Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 27,281 shares @ $1.12, valued at $30.6k
02/17/2022 4 Roth David (Chief Medical Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 125,000 options to buy @ $1.59, valued at $198.8k
Granted 80,000 restricted stock units @ $0
Granted 200,000 restricted stock units @ $0
02/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/21/2018 4 Roth David (Chief Medical Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 75,000 options to buy @ $10.09, valued at $756.8k
02/13/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/29/2016 3 Roth David (Chief Medical Officer) has filed a Form 3 on Syros Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy